Home›People›Melissa McCracken
MM

Melissa McCracken

Partner, Nextech Invest and director at Ambagon Therapeutics.

Director
Updated Nov 18, 2026·Latest SEC filing Feb 7, 2025·Suggest an edit

About Melissa McCracken

Melissa McCracken is a partner, nextech invest and director at Ambagon Therapeutics.

Melissa McCracken first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Melissa McCracken in the role, so the role may have started earlier or lasted longer.

Ambagon Therapeutics Inc.
Partner, Nextech Invest and director
2022 – 2025 · Eindhoven, Netherlands
Develops experimental cancer drugs that stabilize interactions between proteins.

Key Colleagues at Startups

The people Melissa McCracken works with at each company, as listed on that company's latest Form D.

Ambagon Therapeutics Inc. · Form D, Feb 7, 2025
JS
Josh Seidenfeld
Executive officer
Christian Ottmann
Christian Ottmann
Co-Founder & Chief Executive Officer

Sources

  1. SECAmbagon Therapeutics Inc. Form D, filed Feb 7, 2025